A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Elixiron Immunotherapeutics (Hong Kong) Ltd.
The University of Hong Kong
University of Thessaly
NRG Oncology
Korea University
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Duke University
University of Texas at Austin
Centre Hospitalier de Valenciennes
The Hospital for Sick Children
Ottawa Hospital Research Institute
University of Alabama at Birmingham
Dartmouth-Hitchcock Medical Center
Wake Forest University Health Sciences
Thomas Jefferson University
Centre Francois Baclesse
Osijek University Hospital
UNC Lineberger Comprehensive Cancer Center
Stanford University
National Taiwan University Hospital
Parkview Health
Jonsson Comprehensive Cancer Center
Massachusetts General Hospital
Turku University Hospital
University of Alabama at Birmingham
University Medicine Greifswald
Universidad de Córdoba
University of Washington
Appalachian State University
Georgetown University
Universitair Ziekenhuis Brussel
Aarhus University Hospital
University of Nottingham
Amsterdam UMC, location VUmc
Helse Stavanger HF
University Hospital of Ferrara
Baylor University
Fundacion Clinic per a la Recerca Biomédica
Reykjavik University
Region Stockholm
Aarhus University Hospital
Karolinska University Hospital
University of Aarhus